RADIOLOGICAL RESPONSE READINESS
Scaling Radiological Triage
to Alliance Scale.
RadResIQ, powered by MiRAD™, provides alliance-level agencies with Emergency Response as a Service (ERaaS) – enabling rapid, data-driven triage in the first 72 hours of a radiological event.
THROUGHPUT:
> 10,000 results / 24h
TIME TO DECISION:
~ 5 hours
DOSE ACCURACY:
± 1.0 Gy
-
ALLIANCE READINESS SNAPSHOT
Co‑funded with DOD, NIH, NASA
From stockpiles to capability: a new model for radiological defense.
• Standardized biodosimetry assay for alliance-wide triage, aligned with WHO BioDoseNet frameworks.
• Integrates into existing high-throughput molecular labs across member states – no new core hardware required.
• Structured as Vendor-Managed Inventory (VMI) with surge production guarantees for declared crises.
MiRAD™ – Developed at The Ohio State University Wexner Medical Center. Structured and scaled by RadResIQ.
THE STRATEGIC GAP
The 72-Hour Radiological Triage Bottleneck.
In a mass-casualty radiological event, alliance-level response is constrained by a single point of failure: the inability to generate reliable, high-volume biological dose data in time to guide countermeasure deployment and maintain civil order.
What happens without data?
• Hospitals are overwhelmed by the "worried well" long before truly exposed individuals can be prioritized.
• Countermeasures are deployed blindly based on proximity and symptoms, not biological impact.
• Alliance command lacks a common operating picture, forcing reactive, fragmented decision-making.
THE ALLIANCE CHALLENGE.
Alliance-scale resilience requires more than national stockpiles. It requires:
• Interoperable triage protocols across member states.
• Assured surge capacity that can match worst-case threat models.
• A validated mechanism to turn laboratory infrastructure into an operational defense asset.
THE MiRAD™ PLATFORM
Molecular Precision. Alliance Scale.
MiRAD™ is a patented microRNA-based biodosimetry platform developed at The James Comprehensive Cancer Research Hospital at The Ohio State University Wexner Medical Center, with co-funding from NIH/NIAID, DOD-CDMRP, NASA, and state innovation pathways. RadResIQ structures and scales MiRAD™ as a service.
HOW MiRAD™ WORKS.
• Uses a dual-miRNA assay to quantify biological response to ionizing radiation.
• Requires only two drops of blood for minimally invasive, field-adaptable sampling.
• Delivers individual absorbed dose estimates (0–10 Gy) with an accuracy of approximately ± 1.0 Gy.
• Aligned with WHO BioDoseNet frameworks and international emergency preparedness guidelines.
DESIGNED FOR EXISTING INFRASTRUCTURE.
• Standard high-throughput, unidirectional molecular workflow labs.
• Lab networks already configured for large-scale qPCR testing.
• 24/7 staffed facilities that can be rapidly brought into an alliance-wide operational plan.
Key advantages:
• No bespoke instruments required
• Leverages COVID-era lab capacity
• Metrologically traceable workflows
• Finger Prick blood sample, no "blood draw" required
MiRAD™ protocols are engineered for integration into:
PERFORMANCE SPECIFICATIONS:
THROUGHPUT:
> 10,000 results / 24h
Validated in high-density qPCR environments with 24/7 operations.
TIME TO RESULT:
~ 5 hours
Enables decisions within the critical first 72 hours of response.
ANALYTICAL WINDOW:
Up to 7 days post-exposure
Supports both acute triage and residual exposure assessment.
EMERGENCY RESPONSE AS A SERVICE
Preparedness Redefined.
RadResIQ structures MiRAD™ as a strategic capability, not a static stockpile. ERaaS moves radiological preparedness from a one-time purchase to a continuously validated, surge-ready service model.
FROM INVENTORY TO CAPABILITY.
• Vendor-Managed Inventory (VMI):
Assay inventory is rotated and maintained by RadResIQ and its partners.
• Surge production guarantees:
Contractual commitments to scale output in line with alliance-level threat scenarios.
• Operational support:
Crisis-time assistance to optimize lab workflows and logistics during activation.
ALLIANCE-LEVEL ADVANTAGES.
• Predictable, service-based budgeting aligned with long-term preparedness mandates.
• Interoperable protocols that enable a unified triage picture across member states.
• The ability to transform dispersed lab infrastructure into a coordinated, alliance-wide triage network.
Alliance Opportunity.
THE MiRAD™ VMI
CHARTER PROGRAM
RadResIQ is selecting 2–3 national or alliance-level CBRN agencies to co-develop and validate the MiRAD™ Emergency Response as a Service model as a new standard for radiological defense.
CHARTER PARTICIPANT BENEFITS.
✓ Co-design of ERaaS and VMI frameworks tailored to your operational doctrine and threat models.
✓ Full-scale preparedness drills to validate throughput, interoperability, and decision-making workflows.
✓ Lifetime Most-Favored-Nation pricing and priority access to MiRAD™ inventory and surge production.
✓ Immediate uplift in alliance-level radiological preparedness during the program period.
WHO SHOULD ENGAGE?
This program is designed for:
• Alliance-level CBRN coordination bodies.
• National agencies with responsibility for radiological defense across borders.
• Strategic planners seeking to move from theoretical plans to validated, drill-ready capability.
Target audiences:
• NATO & EU structures
• National CBRN leads
• Alliance command planners
Secure a Bilateral Briefing at Munich 2026.
RadResIQ will be available for in-person briefings with alliance-level stakeholders during the Munich Security Conference, February 14–16, 2026, as well as follow-up secure video conferences. Share your details and we will coordinate a session aligned with your organization's role and requirements.